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ABSTRACT 
In our screening program for new bio-active metabolites from marine actinomycetes, a cyclic depsipeptide was 
found in the fermentation medium of marine Strepromyces (SS23/4) isolated from sediments collected from Bay 
off Bengal, vellampattai,Tamilnadu. It showed strong biological activity against gram-positive / gram negative 
bacteria by agar overlay technique. It was taxonomically characterized by the basis of morphological and 
phenotypic characteristics, genotypic data and phylogenetic showing Streptomyces sps.  Bio active compound 
was obtained by solvent extraction and purification using column chromatography followed by reverse phase 
HPLC. The pure compound had potent activity against Mycobacterium tuberculosis and Multi Drug Resistant 
Mycobacterium tuberculosis strains (437RU) at a concentration of 10 µg/mL, and  The minimum inhibitory 
concentration (MIC)  against standard test organisms was found to be 1µg/mL against B.subtilis, E.coli and 
Methicillin resistant Staphylococcus aureus. The compound exhibited potent cytotoxic activity against breast 
carcinoma (MCF-7), melanoma cells (A375), prostate carcinoma (DU145) and lung carcinoma (A549) cells 
with IC values 20µg/ml. The symbiotic Streptomyces capillispiralis MTCC 10471 produces crude antibiotic 
30mg/Lt by using nonoptimized fermentation conditions. The structure of the antibiotic was explained by 1D, 
2D NMR and LC-ESI-MS/MS, MALDI-TOF/MS experiments, revealed that it belongs to cyclic ploy peptide 
Actinomycin D. 
 KEY WORDS: Antimicrobials, marine sediments, Actinomycetes, polypeptides, HPLC, UV, LC-ESI/MS, 
Agar overlay, MIC, Fermentation.  
 
INTRODUCTION 
The  oceans  are  highly  complex  and  house  a  diverse  assemblage  of  microbes  that  occur  in  environments  of  
extreme variations in pressure, salinity, and temperature. Marine Streptomyces have developed unique metabolic 
and physiological capabilities that not only ensure survival in extreme habitats, but also offer the potential to 
produce like antiviral, antibacterial, antitumour, anti-helminthic, insecticidal, immuno-modulator, immuno-
suppressant compounds. A growing number of bioactive metabolites have been explored from marine 
Streptomyces 1, 2, 3, 4, 5, 6. Thus, marine Streptomyces is widely recognized as a significant source of novel 
metabolites for drug discovery 7.The Streptomyces genus had reported two-thirds of the microbial antibiotics 8, 9. 
Here, we report the isolation of the marine sediment associated Streptomyces (SS23/4) authenticated by MTCC, 
IMTECH, and Chandigarh, INDIA as Streptomyces capillispiralis MTCC10471, it is a novel source for 
Actinomycin D. The isolated strain was characterized by morphological, cultural, physiological and molecular 
methods.  
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MATERILAS & METHODS 
Collection of marine samples 
 A set of 63 marine sediment samples were collected in a sterile container by scuba diving at depths of 5 mts, 10 
mts, 20 mts, 35 meters at a distance of about 40kms off the sea shore of Bay of Bengal, Coastal areas of 
Visakhapatnam and Vellampatti for the selective isolation of actinomycetes.  
Isolation of actinomycetes:  
Sediment sample (1gm) was suspended in 10 mL of sterile 5mM phosphate buffer (pH 7.0) and stirred for 1 min 
in a super mixer. After a 10-fold serial dilution 1mL of the suspension was spread on Starch Casein Agar plates 
(g/L: Starch 19, Casein 0.3, KNO3 2, NaCl 2, K2HPO4 2, MgSO4.7H2O 0.05, CaCO3 0.02, FeSO4.7H2O 0.01, 
Agar 20) supplemented with cycloheximide 50 µg/mL and 5µg/mL rifampicin to inhibit fungal and bacterial 
growth respectively and incubated at 280 C for 21 days. After 21 days, actinomycetes colonies were confirmed 
by microscopic /macroscopic examination, and inoculated on selective media (Starch casein agar / Bennett’s 
agar or YEME) agar slants. The slants were incubated at 280 C for 2 weeks.  
Bioactivity screening:  
Agar overlay technique 10 
 The zone of inhibition of all the test organisms were detected using agar overlay technique. Streptomyces 
culture was stabbed on nutrient agar plates and incubated. The plates were exposed to chloroform for 40 min, 
followed by plates were overlaid with 5 ml of nutrient agar (0.7% W/V) inoculated with a test organism. Zones 
of inhibition around the colonies were recorded after 24 hrs at 370 C (Fig.1.)  
Taxonomy   
The morphological, cultural, physical characteristics were determined after growth at 300 C  for  14  days  .The  
media recommended by ISP (International Streptomyces Project) 11. The utilization of carbon sources was tested 
by the growth on Pridham and Gottlieb’s medium containing 1 – 0 % carbon source 12. Morphological 
properties were observed with a scanning electron microscope (SEM) 13. 
 Molecular characterization 14 
 Single isolated colonies of the SS23 strain culture was taken from agar plates and suspended in 50 µL of colony 
lysis solution (10mMol, Tris-HCl, pH 7.5, 10 mM EDTA and 50 µg/mL of proteinase K). The reaction mixture 
was incubated at 550 C for 15 min followed by proteinase K inactivation at 800 C for 10 min. The reaction 
mixture was centrifuged at 10,000 rpm at 40C for 15 min. The supernatant containing genomic DNA was 
directly used as a template in PCR reaction. PCR amplification of full length 16S rRNA gene was carried out 
with eubacterial specific five different primers i.e., 16seq3F_S 
(TACGGCTACCCTTGTTACGACTTCGTCCCAATCGCCAGTCCCACCTTCGACAGCTCC 
57),16seq4F_S( ------------------------ATCGCCAGTCCCACCTTCGACAGCTCC 27),INS16S1R_( ---------------
--------0),16seq2R_S( ------------------------0)16seq4R_S -----------------------------------------0).  
A 25 µL reaction volume PCR was done using 10ng of genomic DNA, 1X reaction buffer (10mM Tris HCl, pH 
8.8 at 250 C, 1.5mM MgCl2, 50 mM KCl and 0.1% Triton X-100), 0.4mM (each) deoxynucleoside 
triphosphates (Invitrogen) and 0.5U of DNA polymerase. The PCR was carried out in an automated Gene Amp 
PCR system 9700 thermal cycler under following conditions: 940 C for 1min (denaturation), 550 C  for  1min  
(annealing), 72 0 C for 10min final (elongation). Obtained PCR product was checked by the agarose gel 
electrophoresis. 
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 Fermentation, Isolation and Extraction:  
The strain SS23/4 was subjected to batch fermentation by shake flask method for isolation of antibiotic 
principles. Spore suspension was prepared, added to 20 mL of the seed medium (g/100mL: Soy bean meal 1g, 
Corn steep liquor 1g, Glucose 1g, CaCO3 0.5g, pH 7.0 ) in a 100 mL conical flask and incubated in shaker at 30 
0C  /220  rpm  for  48  hours.  5  ml  of  seed  culture  was  transferred  to  a  250mL  flask  containing  50  mL  of  the  
production medium (g/100mL: Soya bean meal 1 g, Corn steep liquor 0.5 g, Soluble starch 1 g, Dextrose 0.5 g, 
CaCO3 0.7 g, pH 7.2) in a 250ml conical flask and incubated in shaker at 30 0 C /220 rpm for 6 days. After 
fermentation, the culture was centrifuged, the supernatant and mycelia was washed twice with hexane and 
followed by extraction with 20%V/V of ethyl acetate three times, and then samples were evaporated to dryness. 
The  crude  antibiotic  fraction  was  loaded on the  top  of  a  silica  gel  column chromatography.  The  column was  
developed with increasing solvents polarity (Hexane to Ethyl acetate to Methanol) to give antimicrobial 
fractions.   
 
HPLC-DAD Analyses: 
 The chromatography system consisted of an analytical reverse phase C18 column (Agilent 4.6x150mm), 
attached  to  a  LKB-BROMA  2152  HPLC  system.  20?l  of  the  sample  was  injected  into  the  HPLC  column  
(150×4.6mm) fitted with a guard-column (20×4.6) packed with 5-?m Nucleosil-100 C-18 (Varian) and analyzed 
by gradient elution using 100% water as solvent A and 100% methanol as solvent B in 40 min at a flow rate of 
1ml/minute. Constituents eluting from the column were detected at 226nm, 254nm using a Shimadzu SPD -20A 
UV-VIS detector.  
Mass Determination of the Major Fraction: 
The mass spectrum of HPLC purified active fraction was acquired on an Ultra flex Bruker LC-ESI/MS/MS 
mass spectrometer and MALDI-TOF, equipped with a nitrogen laser of wavelength 337nm.  
Biological activities: 
 Purified compound was evaluated for MIC values against various Gram-positive and Gram-negative bacteria 
test cultures using nutrient broth described by Andrews 15. Bioactive fraction was also tested against 
Mycobacterium tuberculosis, Multi Drug Resistant Mycobacterium tuberculosis strains (437RU) and 
Methicillin resistant Staphylococcus aureus. (Table 5) 
 CYTOTOXIC ACTIVITY  
The antitumor activity of the pure compound was tested according to MTT based cell assay 16 against human 
cell lines from breast carcinoma (MCF-7), melanoma cells (A375), prostate carcinoma (DU145), lung 
carcinoma (A549) cells. The cancer cell lines obtained from National Centre for Cell science (NCCS), Pune, 
India and cultivated in Dulbecco’s Modified Eagle’s red Medium (DMEM).  
RESULTS AND DISCUSSION 
 Taxonomy: 
 The isolate (SS23/4) was able to use various complex and simple media for growth. Cultural and physiological 
characteristics of the producer organism are summarized in Tables 1 and 2, respectively. These data clearly 
indicate that the organism belonged to the grey series of Streptomyces sp. Electron microscopy images revealed 
that the aerial mycelium of strain SS23 was spiral, on maturity it divided and formed spiral spore chains. Each 
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spore chain held about 10 to 20 spores. The size of each elliptical spore was about 880 nm. The surface of the 
spore was smooth, no sclerotic granules, sporangia or zoöspores were observed (Fig.2). 
 Sequence analysis: 
 The phylogenetic studies revealed that SS23 belongs to the Streptomyces sp. ME03-5709A and Streptomyces 
sp. VTT E-99-1329 (A52) were interchanged when the Fitch- Margoliash method was employed (Fig.3). The 
isolate has been deposited in the Microbial Type Culture Collection (MTCC), Chandigarh, India 
(http://www.mtcc.imtech.res.in) as S.capillispiralis MTCC 10471. 
Time course of fermentation for act-D production:  
During the course of fermentation, it was a decrease in the pH of the broth until the point of maximum antibiotic 
titer and afterwards there was an increase in the pH of the broth. The biomass increased during the first six days, 
remained stable, then decreased after the sixth day (144 h) (Fig.4.)  
Purification: 
 Among the 7 fractions (1-23), fraction VI (6-15) showed strong biological activity, a red coloured solid 
(190mg) was obtained after concentrating in vacuo (Fig.5). Fraction VI was purified by using semi preparative 
reverse phase HPLC, the active fraction was eluted at 32.6min/84% methanol: water gradient at 254nm (Fig.6).  
Chemical characterization: 
 The mass of HPLC active fraction was 1255.602 D determined by high-resolution mass spectrometry LC-ESI-
MS/MS and MALDI-TOF. UV absorption bands was observed at 205,210,215,226, 240, 254 and 430 nm 
indicates the presence of quinoid and benzenoid chromophores, the infrared spectrum showed amide carbonyl 
bands (1649 cm-1), aromatic absorptions (1463, 1205, cm-1), and NH and OH (3423cm-1), aliphatic (3423 cm-
1) functionalities. The proton ( 1H )  and carbon (13C)  NMR spectra (Fig.7 &8) data showed the presence of 
amide protons, 14 methyl groups, 4 methylenes, 25 methine carbons, and 6 quaternary carbons and phenoxazone 
moiety. The structure was confirmed by comparison of the 13C NMR and 1H NMR data with the literature 17. 
Analyses by 1H and 13C (Table 3) NMR indicated that bioactive compound is a depsipeptide composed of 10 
amino acid residues and chromophore moiety. The structures of all of the amino acids (valine, proline, methyl 
valine, sracosine, theronine) were determined by 2D-NMR techniques including HMBC, COSY, TOCSY, and 
NOESY. 
Table 3.  1H/13C NMR assignments for actinomycin D 
Residue  group   1H  shift    13C shift 
Thr1   NH   7.43(d)    
  CH?   4.67(d)     56.26    
  CH?   5.17(m)   76.18 
  CH3?   1.28(d)    17.44 
Val2   NH   8.15(d)    
  CH?   3.67(tet)               58.33, 58.47   
  CH?   1.97(m)   32.31 
  CH3?    0.79(d), 0.98(t)      19.63, 19.82 
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Pro3    NH      
  CH?   6.08(d)     58.47    
  CH2?   1.83(m)   32.91 
  CH2?    2.02(m)   23.97 
  CH2?   3.08(m)   52.51 
Sar4   N-CH3   2.56(s)    35.52  
  CH2?   3.90(d)     52.51   
Metval  N-CH3   2.84(d), 2.94(d)  39.34   
  CH?   3.01(d)     71.95   
  CH?   3.29(d)    28.34 
  CH3?   1.12(t)   21.72 
Phenoxazone    7H   7.70 
  8H   7.75 
  4CH3   2.13          7.58 
  6CH3   2.70   14.98 
The LC-ESI-MS mass spectrum of Actinomycin D is characterized by an intense line for the protonated 
molecular ion (M+H) observed at m/z 1255.7  The daughter ion spectra obtained from the protonated molecular 
ion is shown in Fig 9. In application of MS/MS to this peptide followed by collision activation and subsequent 
analysis of the resultant daughter ions. The MS/MS spectrum of (M+H) at m/z 1255 was identical to that of 
actinomycin complex.  
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Fig.9. Mass spectrum showing the mass of parent ion (m/z 1255.7) (top), daughter ions obtained from 
fragmentation of parent ion (Middle) and derived sequence is shown at the bottom 
 
 
CONCLUSION 
We are identified a new bioactive strain S.capillispiralis MTCC10471 from  the  sediment  waters  of  Bay  of  
Bengal. Same metabolite can be produced by taxonomically different groups of microbes. The newly isolated 
strain is unique; it is capable of producing large quantities of major compound Act-D in both extracellular and 
intracellular can be purified easily from the minor antibiotic components. On the basis of spectroscopic studies 
the compound isolated was Actinomycin D. The compound had broad spectrum activity, showed strong 
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cytotoxic activity profile against cell lines A549, DU-145, A375, MCF-7 in vitro, also exhibited potent activities 
against Methicillin resistant Staphylococcus aureus, Multi drug resistant Mycobacterium tuberculosis strains 
(437RU). Previously, S.capliispiralis has never been reported to produce act-D. To our knowledge, 
Streptomyces capillispiralis MTCC10471 is  the  first  reported  antibiotic  producing  strain  from  marine  
sediments. Our report can be considered as a new source for anti tuberculosis drugs and cytotoxic antibiotics.  
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